New England Computer
Inotek Pharmaceuticals is a privately held biotechnology company based in Lexington, MA, focused on developing innovative drugs to address serious ocular diseases. With a deep pipeline of drug candidates targeting conditions such as glaucoma and age-related macular degeneration, Inotek aims to improve patient outcomes through cutting-edge research and development.
The company's lead program, trabodenoson (INO-8875), is a highly selective adenosine mimetic designed to lower intraocular pressure associated with open-angle glaucoma and ocular hypertension. Having successfully completed Phase 1 and Phase 2 clinical trials, trabodenoson has demonstrated a favorable safety profile and significant efficacy, positioning Inotek as a leader in ocular drug development.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.



